News | Peripheral Artery Disease (PAD) | December 29, 2022

Modern Vascular and Local Interventional Radiologist Pair Up To Reduce Unnecessary Amputations in Houston, Texas

Dr. Alexander Shestopalov, MD

December 29, 2022 — Modern Vascular, the national leader in minimally invasive treatment for Peripheral Artery Disease (PAD), welcomes a new managing physician, Alexander Shestopalov, MD, Vascular and Interventional Radiologist to its clinic serving the greater Houston area at 7103 South Peek Rd. #300 in Richmond, TX. Modern Vascular will hold a Physician’s Open House Thursday, January 5th 2023 from 4-7pm complete with a meet & greet, tours of the facility and refreshments.

Dr. Shestopalov is a Board-Certified Vascular & Interventional Radiologist, completing his medical degree at the University of Texas Medical Branch in Galveston, TX. He then completed his radiology residency at Albert Einstein College of Medicine in New York and his vascular and interventional radiology training at Baylor Scott & White in Temple, TX. He is now proud to be working at Modern Vascular stating “the team here in Houston is great, I really enjoy working with the team here.   There's a lot of just good vibes here. Everybody gets a lot of support and we're all trying to work toward a common goal, to get out there in the community and try to help as many patients as we possibly can, because PAD is a very rapid condition.” Prior to joining Modern Vascular, Dr. Shestopalov practiced Vascular and Interventional Radiology at the University of Texas Medical Branch starting a program focused on PAD treatment.

PAD affects approximately 8-12 million Americans. Senior citizens or those with a history of diabetes, smoking, obesity, high blood pressure or high cholesterol may be at a higher risk for PAD. In addition, the rate of lower limb amputation due to PAD is high, as is the rate of death following amputation: nearly 50% after one year, 90% within 5 years. According to the Amputee Coalition, in 2014 there were about 4,000 amputations performed in Missouri mostly due to complications from diabetes and peripheral artery disease. This statistic is especially noteworthy as September is PAD Awareness Month.

Modern Vascular’s purpose is focused on saving limbs and lives, returning patients to their homes and families, the same day and in better health. The company’s mission is to eradicate unnecessary lower leg and foot amputation in the general public and specifically among disadvantaged and underserved communities. Over 90% of PAD related amputations are preventable.

Modern Vascular provides an online PAD quiz for patients to determine if they are at risk for PAD. 

For more information: https://modernvascular.com/


Related Content

News | Peripheral Artery Disease (PAD)

March 20, 2024 — Biotronik has been granted Breakthrough Device Designation (BDD) from the US Food and Drug ...

Home March 20, 2024
Home
News | Peripheral Artery Disease (PAD)

February 12, 2024 — Sensome, a company pioneering the connected medical device revolution with the world’s smallest ...

Home February 12, 2024
Home
News | Peripheral Artery Disease (PAD)

November 10, 2023 —Getinge announced commercial availability of the iCast covered stent system in the United States for ...

Home November 10, 2023
Home
News | Peripheral Artery Disease (PAD)

October 24, 2023 — Four years ago, following a publication based on the limited data available, the U.S. Food and Drug ...

Home October 24, 2023
Home
News | Peripheral Artery Disease (PAD)

September 14, 2023 — LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of ...

Home September 14, 2023
Home
News | Peripheral Artery Disease (PAD)

July 11, 2023 — The U.S. Food and Drug Administration (FDA) is informing healthcare providers about updated information ...

Home July 11, 2023
Home
News | Peripheral Artery Disease (PAD)

June 21, 2023 — A new science report issued by the American Heart Association (AHA) emphasizes the importance of ...

Home June 21, 2023
Home
News | Peripheral Artery Disease (PAD)

June 16, 2023 — Endologix LLC, a privately held, global medical device company, dedicated to providing disruptive ...

Home June 16, 2023
Home
News | Peripheral Artery Disease (PAD)

June 15, 2023 — Endologix LLC, a privately held, global medical device company dedicated to providing disruptive ...

Home June 15, 2023
Home
News | Peripheral Artery Disease (PAD)

March 8, 2023 — Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in ...

Home March 08, 2023
Home
Subscribe Now